Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.
about
Hepatocellular carcinoma and hepatitis B surface proteinRapid and quantitative detection of hepatitis B virusApplications of human hepatitis B virus preS domain in bio- and nanotechnology.Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patientsQuantitative measurement of serum hepatitis B surface antigen using an immunoradiometric assay in chronic hepatitis BPerformance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypesSecretion of genome-free hepatitis B virus--single strand blocking model for virion morphogenesis of para-retrovirus.Evaluation of LIAISON Treponema Screen, a novel recombinant antigen-based chemiluminescence immunoassay for laboratory diagnosis of syphilis.Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virusComparison of three luminescent immunoassays for hepatitis B virus surface antigen quantification during the natural history of chronic hepatitis B virus infection.A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV.Response-guided therapy of regimens based on PEG-interferon for chronic hepatitis B using on-treatment hepatitis B surface antigen quantification: a meta-analysis.Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study.Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients.Elecsys hepatitis B surface antigen quantitative assay: performance evaluation and correlation with hepatitis B virus DNA during 96 weeks of follow-up in chronic hepatitis B patients.Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencingThe correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status.Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in childrenThe role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis BApplication of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.HBsAg Quantification in Clinical Practice.Correlation between hepatitis B surface antigen titers and HBV DNA levelsDevelopment of an electrochemical sensing technique for rapid genotyping of hepatitis B virus.Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.Quantification of HBsAg: basic virology for clinical practiceHBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?Hepatitis B surface antigen quantification in chronic hepatitis B and its clinical utility.Aptamer-based competitive binding assay for one-step quantitation of hepatitis B surface antigen.Randomized prospective study showing the non-inferiority of tenofovir to entecavir in treatment-naïve chronic hepatitis B patients.Dual-Labeled Time-Resolved Immunofluorometric Assay for the Simultaneous Quantitative Detection of Hepatitis B Virus Antigens in Human Serum.Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients.Analysis of HBsAg using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays.Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.
P2860
Q26766123-581075C7-3C72-4813-A40E-6624A289A53FQ26852749-089D9BF7-EA72-42D7-A65D-94E5115FD4A3Q27693188-37C77F38-8CDF-468E-BA5D-534371F5BCA4Q33695646-C4A55CA6-97EC-4ECB-B003-E2E6120E0A04Q33704165-85FC5A12-7ADF-4BE9-A584-924ADAF1583BQ33815041-58407372-C22B-445C-8DDE-7BE635476E20Q34037662-EA85CF9A-FD74-4655-BD46-33334C6F095CQ34072446-A9E1EC1B-19AC-4E1C-B454-DC3E4A8C427CQ34189348-361E19B8-8B55-4362-B9BE-4CBEC00ED906Q34434897-62B8A6BA-9672-461A-B562-B7C0059F0BD7Q34592952-06FE9838-006E-4CFD-BDBA-DD26D2177B57Q34601381-3C0B6E50-3C21-43FB-BA70-EA69E98527FFQ35224148-4008D003-0513-4EA1-A1D2-54E1B86574BBQ35540204-B895F6B0-0FC3-438A-BA14-8A899C6591B7Q35688409-51E30831-513D-4D81-81A1-9AC953F1AFDBQ35739079-D4B35C39-E074-408E-85A9-E62259AD7BF7Q35846564-127B8495-39D7-4D74-8A10-C4A1A8823F8DQ36190007-7D52F959-608A-4A5A-8B9B-7DD3316BA1B4Q36351904-1199A514-6877-47F2-86D5-EDA152C382C2Q36365030-24541388-F01A-4A8B-ADEA-44A1679677FCQ36395364-AD39AB95-8CBB-4A7F-A4B8-783D37808D90Q37166945-237C3265-AD56-4154-A79F-7A256A956293Q37296897-480D07D6-94B9-4B8C-9314-5B17C81439E4Q37380078-CE57AA05-6BEC-4C40-9CBA-4B940F5D1284Q37470263-3B8D51A8-9B34-4FFC-8DA1-5638D23481ACQ37614037-DDA5277F-1951-4B58-8CD3-23A236EAA8E8Q37645703-234CD51B-D66C-4CB2-AD6E-C47B31F0CD98Q37731087-75D4352A-8519-4023-AFFA-B78C3AD0CB87Q37762545-F3671B60-B20F-4480-BEE3-050D6B565716Q37831142-980D76EF-3443-45FA-9641-17A337EC704DQ38174261-CA8D9102-39B4-47F9-A16A-0F033B220E2DQ38177851-3DCB674C-F2ED-49AA-B069-105C3A0A9A3FQ38306046-2D8B0062-531B-4C63-A39F-280DB2AAB1C2Q38856880-E9A4BB9C-1D1C-4C45-96E3-366E7039F657Q39178448-CA29718F-924B-4BE0-9B4C-29317B7C070BQ39558394-2F1CCCAA-63ED-4BEE-AF3C-456C61076C22Q39736089-2B33934A-4672-4DE4-A99D-3AD1C7305AEFQ40051443-E37C5085-9EAE-47E6-B5A9-22E7F850AF06Q40404341-A094E853-3FFD-47B5-AB93-B62F1B531899Q40423840-387DA996-9BA7-445D-8691-AE75B08BF2EC
P2860
Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@en
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@nl
type
label
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@en
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@nl
prefLabel
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@en
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@nl
P2093
P1476
Quantitation of hepatitis B su ...... ent microparticle immunoassay.
@en
P2093
Isa K Mushahwar
Kazushige Iinuma
Masanori Kagita
Matsuo Deguchi
Naoko Yamashita
Seishi Asari
Takahiko Tsuchida
Yoshinori Iwatani
P304
P356
10.1016/J.JVIROMET.2003.10.002
P577
2004-02-01T00:00:00Z